A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens

Pharmacogenetics and Genomics

Volumn 20, Issue 10, 2010, Pages 598-604

  Horn, Heike ^a   Pott, Christiane ^c   Kalla, Jörg ^d   Dreyling, Martin ^e   Rosenwald, Andreas ^f   Ott, German ^d   Schwab, Matthias ^a,b   Schaeffeler, Elke ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d ROBERT BOSCH HOSPITAL   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

follicular lymphoma; formalin fixed paraffin embedded tissue; genotyping; MALDI TOF MS; multiplex; single nucleotide polymorphism

Indexed keywords

DNA; FORMALDEHYDE; PARAFFIN;

AMPLICON; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DNA EXTRACTION; DNA ISOLATION; FOLLICULAR LYMPHOMA; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77957222519     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32833deb16     Document Type: Article

References (32)

1. Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007; 109:5439-5446. (Pubitemid 46890567)
2. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007; 110:4455-4463. (Pubitemid 351377812)
3. De Roos AJ, Gold LS,Wang S, Hartge P, Cerhan JR, Cozen W, et al. Metabolic gene variants and risk of non-Hodgkins lymphoma. Cancer Epidemiol Biomarkers Prev 2006; 15:1647-1653. (Pubitemid 44497100)
4. Hohaus S, Mansueto G, Massini G, DAlo F, Giachelia M, Martini M, et al. Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkins Lymphoma. Leuk Lymphoma 2007; 48:564-569. (Pubitemid 46499175)
5. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006; 107:4101-4108. (Pubitemid 43726819)
6. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 2007; 28:704-712. (Pubitemid 46523368)
7. Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, Paynter RA, et al. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS One 2008; 3:e2816.
8. Smedby KE, Lindgren CM, Hjalgrim H, Humphreys K, Schollkopf C, Chang ET, et al. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev 2006; 15:258-265. (Pubitemid 43342172)
9. Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007; 67:5042-5054. (Pubitemid 46910215)
10. Jaremko M, Justenhoven C, Abraham BK, Schroth W, Fritz P, Brod S, et al. MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum Mutat 2005; 25:232-238. (Pubitemid 40365141)
11. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th edition. Lyon, France: IARC Press; 2008.
12. Geisler T, Schaeffeler E, Dippon J, Winter S, Buse V, Bischofs C, et al. CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics 2008; 9:1251-1259.
13. Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Sante-Poku S, Zanger UM, et al. Frequency of C3435 T polymorphism of MDR1 gene in African people. Lancet 2001; 358:383-384. (Pubitemid 32739101)
14. Sambrook JE, Frisch EF, Maniatis T. Molecular cloning: a laboratory manual. Harbor, New York: Cold Spring Harbor Press, Cold Spring; 1989.
15. Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD. Genotyping for polymorphic drug metabolizing enzymes from paraffinembedded and immunohistochemically stained tumor samples. Pharmacogenetics 2003; 13:501-507.
16. Schaeffeler E, Zanger UM, Eichelbaum M, Sante-Poku S, Shin JG, Schwab M. Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups. Clin Chem 2008; 54:1637-1647.
17. Blow N. Tissue preparation: tissue issues. Nature 2007; 448:959-963. (Pubitemid 47312767)
18. Gilbert MT, Haselkorn T, Bunce M, Sanchez JJ, Lucas SB, Jewell LD, et al. The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS One 2007; 2:e537.
19. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chipbased matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001; 98:581-584. (Pubitemid 32105085)
20. Kim S, Ruparel HD, Gilliam TC, Ju J. Digital genotyping using molecular affinity and mass spectrometry. Nat Rev Genet 2003; 4:1001-1008. (Pubitemid 37474647)
21. Ragoussis J, Elvidge GP, Kaur K, Colella S. Matrix-assisted laser desorption/ ionisation, time-of-flight mass spectrometry in genomics research. PLoS Genet 2006; 2:e100. (Pubitemid 44147397)
22. Ross P, Hall L, Smirnov I, Haff L. High level multiplex genotyping by MALDITOF mass spectrometry. Nat Biotechnol 1998; 16:1347-1351. (Pubitemid 28547446)
23. Tost J, Gut IG. Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications. Clin Biochem 2005; 38:335-350. (Pubitemid 40342864)
24. Perkel J, Blow N. SNP genotyping: six technologies that keyed a revolution. Nature Methods 2008; 5:447-453. (Pubitemid 351619104)
25. McWhinney SR, McLeod HL. Using germline genotype in cancer pharmacogenetic studies. Pharmacogenomics 2009; 10:489-493.
26. Legrand B, Mazancourt P, Durigon M, Khalifat V, Crainic K. DNA genotyping of unbuffered formalin fixed paraffin embedded tissues. Forensic Sci Int 2002; 125:205-211. (Pubitemid 34224146)
27. Cao W, Hashibe M, Rao JY, Morgenstern H, Zhang ZF. Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells. Cancer Detect Prev 2003; 27:397-404. (Pubitemid 37365555)
28. Blomeke B, Bennett WP, Harris CC, Shields PG. Serum, plasma and paraffin-embedded tissues as sources of DNA for studying cancer susceptibility genes. Carcinogenesis 1997; 18:1271-1275. (Pubitemid 28132521)
29. Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 2009; 114:826-834.
30. OShea D, ORiain C, Gupta M,Waters R, Yang Y,Wrench D, et al. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood 2009; 113:2298-2301.
31. Fumagalli D, Gavin PG, Taniyama Y, Kim SI, Choi HJ, Paik S, et al. A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes. BMC Cancer 2010; 10:101.
32. Lips EH, Dierssen JW, van ER, Oosting J, Eilers PH, Tollenaar RA, et al. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. Cancer Res 2005; 65:10188-10191. (Pubitemid 41743709)